Bienvenido, invitado! | iniciar la sesión
US ES

Activity Stream

MoatRx
@moatrx3 weeks ago
Posted a new blog:
US HR+/HER2- BREAST CANCER Competitive Intelligence
Ribociclib is the only CDK4/6 inhibitor with a significant survival edge: 63.9 versus 51.4 months, while palbociclib's OS gain never reached significance. The...

Tags

Dislike 0
MoatRx
Seguidores:
bestcwlinks willybenny01 beejgordy quietsong vigilantcommunications avwanthomas audraking askbarb artisticsflix artisticflix aanderson645 arojo29 anointedhearts annrule rsacd
Recientemente clasificados:
estadísticas
Blogs: 120